Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Lung Cancer ; 21(1): 1-6, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9792048

ABSTRACT

Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery alone. We have now re-analyzed the results of the study with a median time from random allocation to analysis for all patients of 82 months. The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/drug therapy , Lung Neoplasms/surgery , Chemotherapy, Adjuvant , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...